companydata.dkAMPLEXA GENETICS A/S: Financial statements 2025
CVR: 29428441
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. That is an increase of 18% compared with the year before. Equity amounted to DKK -10,313,267. The company had 12 employees in the financial year.
- Gross Profit
- 4,009,035 kr.
- Profit/Loss
- -1,583,233 kr.
- Equity
- -10,313,267 kr.
- Total Assets
- 2,892,496 kr.
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 4 mio. | -1.6 mio. | -10.3 mio. | 12 |
| 2024 | - | 3.4 mio. | -11.1 mio. | -8.7 mio. | 14 |
| 2023 | - | 3.2 mio. | -3.1 mio. | 2.4 mio. | 15 |
| 2022 | - | 5.5 mio. | -2.3 mio. | -14.5 mio. | 14 |
| 2021 | - | 20.3 mio. | 12.3 mio. | -12.2 mio. | 13 |
Find more companies like AMPLEXA GENETICS A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
AMPLEXA GENETICS A/S has published its annual report for 2024. Gross profit came to DKK 3,398,662, and the net result was DKK -11,108,344.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.